{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:41:33Z","timestamp":1760924493305,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.biologicals.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:26:13Z","timestamp":1565655973000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model"],"prefix":"10.1016","volume":"61","author":[{"given":"Anshul","family":"Varshney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P.","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijai","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12998\/wjcc.v3.i1.20","article-title":"Anthrax: a disease of biowarfare and public health importance","volume":"3","author":"Goel","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.biologicals.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010714","article-title":"New insights into the functions of anthrax toxin","volume":"8","author":"Banks","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.biologicals.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.5.4.417","article-title":"Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine","volume":"5","author":"Keitel","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1074\/jbc.M109997200","article-title":"Mapping the anthrax protective antigen binding site on the lethal and edema factors","volume":"277","author":"Lacy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in Guinea-pigs","volume":"12","author":"Ivins","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.07.004_bib11","first-page":"167","article-title":"The anthrax vaccine: is it safe? Does it work?","volume":"27","author":"Bhatanagar","year":"2001","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(02)00359-4","article-title":"Therapeutic challenges posed by bacterial bioterrorism threats","volume":"5","author":"Gilligan","year":"2002","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1007\/s00253-016-7684-4","article-title":"Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model","volume":"100","author":"Suryanarayana","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biologicals.2019.01.001","article-title":"An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India","volume":"57","author":"Varshney","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.07.004_bib15","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/CVI.00154-12","article-title":"Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India","volume":"19","author":"Ghosh","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3181\/00379727-57-14776","article-title":"Estimation of the ED50 and its error by means of logarithmic-probit graph paper","volume":"57","author":"Miller","year":"1944","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.biologicals.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jat.1114","article-title":"Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route","volume":"26","author":"Kulkarni","year":"2006","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00430-019-00577-x","article-title":"Development of a novel multiepitope chimeric vaccine against anthrax","volume":"208","author":"Aggarwal","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib19","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1128\/AAC.00640-10","article-title":"A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine","volume":"54","author":"Wu","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biologicals.2019.07.004_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1875035400902010092","article-title":"Anthrax LFn-PA hybrid antigens: biochemistry, immunogenicity, and protection against lethal Ames spore challenge in rabbits","volume":"2","author":"Li","year":"2009","journal-title":"Open Vaccine J"},{"key":"10.1016\/j.biologicals.2019.07.004_bib21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","article-title":"Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis","volume":"46","author":"Kaur","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/iai.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2019.07.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2157-2526.1000147","article-title":"Development of recombinant domains of protective antigen of Bacillus anthracis and evaluation of their Immune response in mouse model for use as vaccine candidates for anthrax","volume":"7","author":"Varshney","year":"2016","journal-title":"J Bioterrorism Biodefense"},{"key":"10.1016\/j.biologicals.2019.07.004_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.molimm.2010.08.001","article-title":"GroEL provides protection against Bacillus anthracis infection in BALB\/c mice","volume":"48","author":"Sinha","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2019.07.004_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MMBR.68.4.617-629.2004","article-title":"Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines","volume":"68","author":"Phipps","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.biologicals.2019.07.004_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000097283","article-title":"Neuronal expression of tumor necrosis factor alpha in the murine brain","volume":"3","author":"Gahring","year":"1996","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biologicals.2019.07.004_bib28","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes","volume":"184","author":"Ingram","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2019.07.004_bib29","doi-asserted-by":"crossref","first-page":"e0148713","DOI":"10.1371\/journal.pone.0148713","article-title":"A comparison of the adaptive immune response between recovered anthrax patients and individuals receiving three different anthrax vaccines","volume":"11","author":"Laws","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.07.004_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0002-9440(10)63697-8","article-title":"Pathology and pathogenesis of bioterrorism-related inhalational anthrax","volume":"163","author":"Guarner","year":"2003","journal-title":"Am J Pathol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561930079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561930079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:01Z","timestamp":1760922841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510561930079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"alternative-id":["S104510561930079X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.07.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}